(Q53256324)

12 May 2018

title

Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis. (English)

1 reference

12 May 2018

1 reference

6

1 reference

12 May 2018

author name string

Michelle Reid-Nicholson

1

1 reference

12 May 2018

Pratibha Iyengar

2

1 reference

12 May 2018

Amanda J Hummer

3

1 reference

12 May 2018

Irina Linkov

4

1 reference

12 May 2018

Marina Asher

5

1 reference

12 May 2018

publication date

28 April 2006

1 reference

12 May 2018

published in

Modern Pathology

1 reference

12 May 2018

volume

19

1 reference

12 May 2018

issue

8

1 reference

12 May 2018

page(s)

1091-1100

1 reference

12 May 2018

https://scigraph.springernature.com/pub.10.1038/modpathol.3800620

exact match

0 references

cites work

Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800620

Distinction between endocervical and endometrial adenocarcinoma with immunoperoxidase staining of carcinoembryonic antigen in routine histological tissue specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800620

Hormone receptor immunohistochemistry and human papillomavirus in situ hybridization are useful for distinguishing endocervical and endometrial adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800620

Immunohistochemical staining in the distinction between primary endometrial and endocervical adenocarcinomas: another viewpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800620

Tissue microarrays for high-throughput molecular profiling of tumor specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800620

The INK4a/ARF network in tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800620

The RB and p53 pathways in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800620

Tumor suppression by Ink4a-Arf: progress and puzzles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800620

Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800620

Human papillomaviruses, expression of p16, and early endocervical glandular neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800620

Immunohistochemical overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800620

Immunohistochemical staining with MIB1, bcl2 and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800620

p16INK4A alterations are accompanied by aberrant protein immunostaining in endometrial carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800620

Cyclin D1 expression in high-grade endometrial carcinomas--association with histologic subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800620

Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800620

Immunohistochemical analysis of clear cell carcinoma of the gynecologic tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800620

The hormonal receptor status of uterine carcinosarcomas (mixed müllerian tumours): an immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800620

Immunohistochemical Evaluation of Estrogen and Progesterone Receptor Content in 183 Patients with Endometrial Carcinoma: Part I: Clinical and Histologic Correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800620

Immunohistochemical Evaluation of Estrogen and Progesterone Receptor Content in 183 Patients with Endometrial Carcinoma: Part II: Correlation Between Biochemical and Immunohistochemical Methods and Survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800620

Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800620

Two pathogenetic types of endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800620

p16 immunoreactivity may assist in the distinction between endometrial and endocervical adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800620

7 January 2021

p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800620

7 January 2021

The immunohistochemical discrimination of endometrioid adenocarcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800620

7 January 2021

A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800620

7 January 2021

Macrophage-derived chemokine expression in classical Hodgkin's lymphoma: application of tissue microarrays

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800620

7 January 2021

P16INK4A positivity in benign, premalignant and malignant cervical glandular lesions: a potential diagnostic problem

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800620

7 January 2021

A panel of immunohistochemical stains assists in the distinction between ovarian and renal clear cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800620

7 January 2021

Estradiol and progesterone receptors in gynecologic sarcomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800620

7 January 2021

Immunohistochemical analysis of p53 protein over-expression in endometrial carcinomas: inverse correlation with sex steroid receptor status

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800620

7 January 2021

Immunohistochemical comparison of uterine papillary serous and papillary endometrioid carcinoma: clues to pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800620

7 January 2021

Distinction Between Endometrial and Endocervical Adenocarcinoma: An Immunohistochemical Study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800620

7 January 2021

10.1038/MODPATHOL.3800620

Identifiers

DOI

1 reference

12 May 2018

OpenCitations bibliographic resource ID

0 references

1 reference

12 May 2018